Do for blood bank reagents, korea 06-13-2024 to 9-30-2024
Ended Awarded Last action
- Contract number
- W81K0224F0085
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $35,616
Award facts
- Opportunity
-
- Blood Bank Reagents Solicitation · W81K0223Q0027 · Posted Feb 10, 2023
- Contract value 100% obligated
- $35,616.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a delivery order to Immucor Inc. on June 14, 2024, for the supply of blood bank reagents to support operations in Korea. This firm fixed-price delivery order, with a ceiling value of $35,616.26, represents a direct procurement with no set-aside designation and is scheduled for completion by September 30, 2024. Immucor, headquartered in Norcross, Georgia, is a specialized manufacturer of in vitro diagnostic products and blood banking reagents that has maintained an established relationship with federal healthcare agencies since 2001.
This delivery order likely derives from one of Immucor's existing blanket purchase agreements or indefinite delivery contracts with the Defense Health Agency, which currently maintains a $1.02 million BPA with the company through March 2027. Blood bank reagents are essential consumables for transfusion compatibility testing and blood typing operations, critical functions within military medical treatment facilities. The award supports the Defense Health Agency's mission to provide comprehensive healthcare services to the military population, with performance occurring at Immucor's Norcross facility for delivery to Korea-based operations.
Quick answers
Who was awarded contract W81K0224F0085?
W81K0224F0085 was awarded to Immucor Inc. by Medical Command (Department of the Army) on June 14, 2024.
How much is contract W81K0224F0085 worth?
The government has obligated $35,616 on W81K0224F0085.
Which agency awarded contract W81K0224F0085?
Medical Command (Department of the Army) awarded W81K0224F0085, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0085 an order under another contract?
Yes. W81K0224F0085 is a delivery order under W81K0223D0001, an indefinite delivery contract.
Was contract W81K0224F0085 competed?
The extent of competition for W81K0224F0085 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award